Perspective Therapeutics (CATX) Tax Rate (2023)
Perspective Therapeutics recorded quarterly Tax Rate of 135.08% in Q4 2023, down 239.86% quarter-over-quarter from 96.59% in Q1 2023.
Perspective Therapeutics' Tax Rate history runs 1 years deep, the most recent figure standing at 135.08% for Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 25.67 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.35 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 18.09 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -15.15 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 17.06 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -23.16 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 25.97 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 18.61 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 27.65 |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -135.08 |
| Dec 31, 2023 | -135.08 |
| Mar 31, 2023 | 96.59 |
| Mar 31, 2023 | 96.59 |